Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jacobsen

Showing results (421-430 of 488) with videos related to

Pageof 49
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2023
Soluble Enolase 1 of Candida albicans and Aspergillus fumigatus Stimulates Human and Mouse B Cells and MonocytesDaniela Langenhorst, Anna-Lisa Fürst, Karl Alberter, et al.
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
The Journal of Experimental Biology|December 20, 2013
Stress adaptation in a pathogenic fungusAlistair J P Brown, Susan Budge, Despoina Kaloriti, et al.
Journal of the American Chemical Society|June 29, 2022
Synthesis of the Candidate Topological Compound Ni<sub>3</sub>Pb<sub>2</sub>Alexandra D Tamerius, Alison B Altman, Michael J Waters, et al.
Eukaryotic Cell|April 10, 2007
Molecular phylogenetics of Candida albicansFrank C Odds, Marie-Elisabeth Bougnoux, Duncan J Shaw, et al.
Nature Communications|May 13, 2020
Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesiclesLuke D Halder, Emeraldo A H Jo, Mohammad Z Hasan, et al.
ESMO Open|September 18, 2022
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatmentE Aamdal, E Skovlund, K D Jacobsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell LymphomaNeha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
Pageof 49

Showing results (421-430 of 488) with videos related to

Sort By:
Pageof 49
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2023
Soluble Enolase 1 of Candida albicans and Aspergillus fumigatus Stimulates Human and Mouse B Cells and MonocytesDaniela Langenhorst, Anna-Lisa Fürst, Karl Alberter, et al.
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
The Journal of Experimental Biology|December 20, 2013
Stress adaptation in a pathogenic fungusAlistair J P Brown, Susan Budge, Despoina Kaloriti, et al.
Journal of the American Chemical Society|June 29, 2022
Synthesis of the Candidate Topological Compound Ni<sub>3</sub>Pb<sub>2</sub>Alexandra D Tamerius, Alison B Altman, Michael J Waters, et al.
Eukaryotic Cell|April 10, 2007
Molecular phylogenetics of Candida albicansFrank C Odds, Marie-Elisabeth Bougnoux, Duncan J Shaw, et al.
Nature Communications|May 13, 2020
Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesiclesLuke D Halder, Emeraldo A H Jo, Mohammad Z Hasan, et al.
ESMO Open|September 18, 2022
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatmentE Aamdal, E Skovlund, K D Jacobsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell LymphomaNeha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
Pageof 49